Printer Friendly

Articles from Chain Drug Review (February 4, 2019)

1-34 out of 34 article(s)
Title Author Type Words
... gadgets, monitors, devices, mobile technology. 704
Accordant gets three-year accreditation. 375
Aetna helps create network with blockchain. 265
Albertsons reports strong Q3 gains in sales, earnings. Financial report 674
App restores era of house calls. 673
Aveeno collection offers farm-fresh ingredients. 446
Cardinal names Rice executive VP. 229
Case for DIR reform advanced. 244
CBD is the hottest thing around. 350
CFUs praised as unit of measure. 504
Chains show interest in Brownmed launch. 249
Creams, oils top the list of topical delivery forms. Statistical data 1196
CVS to disclose all beauty image edits. 396
CVS, Walmart reach agreement on pharmacy contract. 385
First aid spotlight falls on insect bites, bruises rashes. Medical condition overview 787
For probiotics category, the best is yet to come. 1001
Greater stress, more GI problems, O-T-Cs proliferate. 1066
Hair growth system unveiled. 343
Home health care: everyone sees a need for ... 945
Hy-Vee adopts new opioid policy. 252
Investment by Combe in women's wellness. 229
Jhaveri appointed Health Mart president. 798
Lampert's bid for Sears stores. 117
Majority of customers prefer brick-and-mortar. 397
Organic solutions have clout. 388
Pain's everywhere; non-Rx treatments make gains. 864
PainBloc24 taps highest allowable capsaicin level. 659
Target holiday sales grow online and off-line. 432
Unilever's new home care brand. 198
WBA in settlement of improper billing claims. 256
WBA joins Microsoft in health care partnership. 642
WBA's dramatic shift to digital-first model. Woldt, Jeffrey 1035
Wider role for CVS' Sansone. 159
Year-to-Date Stock Trends. 556

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |